NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), works to acquire licensing for commercial use of NASA-developed stem cell expansion technology, the company received good news from a Wall Street analyst’s forecast on Wednesday.
